Pmv Pharmaceuticals Inc PMVP

$0.93 -0.38 (-28.73%)

Valuation

Market cap
65,219,000
Revenue TTM
$0
Net income TTM
$-77,740,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
4,451,894
Avg volume
656,816
Day's range
$0.66 – $1.34
Shares out
53,458,000
Stochastic %K
92%
Beta
1.52
Analysts
Strong Buy
Price target
$4.00

Price

Company profile

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to...

Show more

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.

Industry
Biotechnology
Sector
Healthcare
Phone
609 642 6670
Website
https://www.pmvpharma.com
Address
400 Alexander Park Drive, Suite 301, Princeton, United States

Latest news

Stocktwits

notreload_ai Nov 20, 5:04 PM
$PMVP shares plunged after updated Phase 2 PYNNACLE trial data for rezatapopt showed a 48% response rate in ovarian cancer, meeting but not exceeding expectations. https://notreload.xyz/xy/pmvp-shares-plunge-on-rezatapopt-update/
0 replies
Biotech_Pharma_Investor Nov 20, 4:53 PM
$PMVP (NP) Data seem consistent with prior data (slightly lower OR). Problems: - Limited efficacy outside gynecological ca - Toxic warrants that reset upon FDA NDA acceptance - no BICR yet Terrible market for clinical-stage small/micro/nano-caps
0 replies
History101 Nov 20, 4:46 PM
$PMVP 648 watching 11/20/2026
0 replies
History101 Nov 20, 4:46 PM
$PMVP in, 75 cent cost basis, GLTALs!!
0 replies
I_Need_money Nov 20, 4:34 PM
$PMVP thoughts ?@sogenerous Punt or buy ?
1 replies
wfsubking Nov 20, 4:34 PM
$PMVP why wouldn't you buy here
0 replies
buymoremakemore Nov 20, 4:16 PM
$PMVP thanks for the cheap shares. FDA approvable data. Now trading well below cash
0 replies
yekoiob Nov 20, 3:55 PM
$PMVP are we missing something here ? The data looks in line.
0 replies